Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000080255-25-000371
Filing Date
2025-05-14
Accepted
2025-05-14 10:45:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5858
  Complete submission text file 0000080255-25-000371.txt   7644
Mailing Address P.O. BOX 89000 BALTIMORE MD 21289
Business Address 100 EAST PRATT ST BALTIMORE MD 21202 (410)345-2000
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) CIK: 0000080255 (see all company filings)

EIN.: 520556948 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
(CF Office: 09 Crypto Assets)

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91525 | Film No.: 25943413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)